\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Digital, Industry & Space HPC AI ContinentThe FFPlus project has opened the first out of six round of open calls to set up experiments with supercomputers and to scale up generative AI applications.
FFplus is a European initiative highlighting and promoting the adoption of High-Performance Computing (HPC) by SMEs and start-ups across Europe, showing the business benefits and impacts of adopting HPC and AI in real business models.
There are two types of open calls:
More information can be found on the FFPlus website, for questions you can also contact the Flemish Supercomputer Center (VSC) via this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
